Stem cell therapy for stable coronary artery disease
Part of Heart & circulation clinical trials.
This trial tests a new stem cell treatment (HeXell-2020) for people with stable coronary artery disease. It aims to see if it's safe and can improve heart function. You may be eligible if you have stable angina and are on regular heart medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have stable coronary artery disease with at least one blocked artery (50% or more) seen on a heart imaging test in the past year.
- You must have stable angina (chest pain with activity) and be on steady heart medications for at least 4 weeks.
- You cannot have a blood clot in your heart or a ventricular aneurysm (a bulging heart wall).
- You must not have had a heart attack, stroke, or major heart surgery in the past 90 days.
- You must not be pregnant, and if you can have children, must use effective birth control during the study and for 4 weeks after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new stem cell treatment for people with widespread coronary artery disease (narrowing of heart blood vessels) that causes chest pain. The treatment aims to improve blood flow and reduce symptoms, even for those who are not good candidates for other procedures.
This trial tests a new gene therapy (XC001) delivered through a thin tube into your heart's blood vessels. It aims to grow new blood vessels to relieve chest pain in people with chronic angina who have no other treatment options.
This trial tests a new device to improve the expansion of stents in heart arteries that are not fully opened. If you are having a stent placed for blocked arteries, this study may help ensure the stent works better to restore blood flow.
This trial tests whether an inhaled medication called Aroxxen® can protect your heart during a planned stent procedure. It may help reduce stress on the heart muscle.
This study tests a new way to treat long, narrow blockages in the heart's arteries. It combines a temporary scaffold with a drug-coated balloon, which may help the artery heal without a permanent metal stent. This could be an option for people who need their artery opened but may benefit from a less permanent approach.
This trial tests if umbilical cord stem cells, given alongside standard care, can help people who have had a major heart attack (STEMI). The cells are infused into the heart artery to possibly improve heart function. You may qualify if you are between 20 and 76, had a heart attack within the last 12 hours, and received a stent, and your heart's pumping ability is moderately reduced.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.